The Role of Regulatory B Cells in Patients with Acute Myeloid Leukemia

Background Regulatory B (Breg) cells are a group of B cells with immunomodulatory function, which mainly exert negative immunomodulatory function by secreting IL-10 and other cytokines. Due to their immunoregulatory properties, Breg cells may participate in the pathogenesis of acute myeloid leukemia (AML). This study was designed to explore the frequency of Breg cells and the relationship between the Breg cells and clinical data in patients with AML. Material/Methods A total of 46 (36 in peripheral blood, 10 in bone marrow) AML patients and 15 healthy donors (HD) were included for detection of Breg cells frequency by multicolor flow cytometry. All cases were divided into different groups according to FAB subtypes of leukemia, white blood cell count (WBC) levels, age, cytogenetic characteristics, and molecular abnormalities, and were compared the differences of Breg cell frequency. Survival curve analysis was performed to estimate the value of Breg cell frequency in prognosis among cases with AML. Results We found that the frequency of Breg cells was higher in AML patients both in peripheral blood (PB) and in bone marrow (BM) compared with those in HDs. The AML patients with high WBC levels had higher Breg cell frequency compared with those with low WBC levels. Low-risk patients with had lower Breg cells frequency compared to the medium-risk patients. The patients with high WBC and high Breg cells frequency showed a shorter overall survival. Similarly, the overall survival of AML patients in the older group with high Breg cells frequency was significantly shorter than in the younger group with low Breg cell frequency. Conclusions For AML patients, the frequency of Breg cells was elevated, and high frequency of Breg cells may reveal poor prognosis.

[1]  P. Heeringa,et al.  Circulating CD24hiCD38hi regulatory B cells correlate inversely with the ThEM17 cell frequency in granulomatosis with polyangiitis patients. , 2019, Rheumatology.

[2]  S. Deng,et al.  Identification of the Subsets of IL-10-Producing Regulatory B Cells in the Course of Tolerance Induction and Maintenance in Islet Allotransplantation. , 2018, Transplantation proceedings.

[3]  A. Antonelli,et al.  Breg Cells in Celiac Disease Isolated or Associated to Hashimoto's Thyroiditis , 2018, International journal of endocrinology.

[4]  I. Burney,et al.  Levels of regulatory T cells and invariant natural killer cells and their associations with regulatory B cells in patients with non-Hodgkin lymphoma. , 2018, Molecular and clinical oncology.

[5]  F. Bolgert,et al.  Regulatory B cells in myasthenia gravis are differentially affected by therapies , 2018, Annals of clinical and translational neurology.

[6]  S. Koo,et al.  The prognostic impact of lymphocyte subsets in newly diagnosed acute myeloid leukemia , 2018, Blood research.

[7]  M. Goswami,et al.  Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy , 2017, Journal of Translational Medicine.

[8]  N. Zhao,et al.  Reduction in Peripheral CD19+CD24hCD27+ B Cell Frequency Predicts Favourable Clinical Course in XELOX-Treated Patients with Advanced Gastric Cancer , 2017, Cellular Physiology and Biochemistry.

[9]  A. Meyerhans,et al.  Calcineurin and mTOR inhibitors have opposing effects on regulatory T cells while reducing regulatory B cell populations in kidney transplant recipients. , 2016, Transplant immunology.

[10]  A. Gruppi,et al.  The regulatory role of B cells in autoimmunity, infections and cancer: Perspectives beyond IL10 production , 2015, FEBS letters.

[11]  Yan Wang,et al.  Clinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer , 2015, Central-European journal of immunology.

[12]  H. Wulan,et al.  Regulatory B Cell Function Is Suppressed by Smoking and Obesity in H. pylori-Infected Subjects and Is Correlated with Elevated Risk of Gastric Cancer , 2015, PloS one.

[13]  T. Miyagaki.  [Regulatory B cells in human autoimmune diseases]. , 2015, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

[14]  Chang Xian Li,et al.  Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway. , 2014, Cancer letters.

[15]  Wei Wei,et al.  Dynamic analysis of tumor-associated immune cells in DEN-induced rat hepatocellular carcinoma. , 2014, International immunopharmacology.

[16]  H. Li,et al.  Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10 , 2014, Leukemia.

[17]  Yan Li,et al.  The Roles of Regulatory B Cells in Cancer , 2014, Journal of immunology research.

[18]  Xiao-jun Huang,et al.  CD19+CD24highCD38high B cells exhibit higher ability in TGF-β and IL-10 secretion and suppressing of CD4+ T cell proliferation but are quantitatively decreased in G-BM of healthy donors (P2146) , 2013, The Journal of Immunology.

[19]  D. Isenberg,et al.  CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation , 2013, Science Translational Medicine.

[20]  R. Watanabe,et al.  Regulatory B Cells (B10 Cells) Have a Suppressive Role in Murine Lupus: CD19 and B10 Cell Deficiency Exacerbates Systemic Autoimmunity , 2010, The Journal of Immunology.

[21]  D. Isenberg,et al.  CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. , 2010, Immunity.

[22]  H. Dombret,et al.  A white blood cell index as the main prognostic factor in t ( 8 ; 21 ) acute myeloid leukemia ( AML ) : a survey of 161 cases from the French AML Intergroup , 2002 .

[23]  B. Johansson,et al.  Poor survival in t(8;21)(q22;q22)‐associated acute myeloid leukaemia with leukocytosis , 1997, European journal of haematology.

[24]  H. Kantarjian,et al.  Association of granulocytosis with poor prognosis in patients with acute myelogenous leukemia and translocation of chromosomes 8 and 21. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.